Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-041718
Filing Date
2014-06-16
Accepted
2014-06-16 18:56:12
Documents
1
Period of Report
2014-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10556
  Complete submission text file 0001209191-14-041718.txt   11961
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Issuer) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
KAPLAN GILLA (Reporting) CIK: 0001247024 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34912 | Film No.: 14923932